Palácová, Markéta. “Sacituzumab Govitecan in the Treatment of Metastatic Triple Negative Breast Cancer”. Onkologie, vol. 17, no. 3, 2023, pp. 160-3, https://doi.org/10.36290/xon.2023.032.
Palácová, M. (2023). Sacituzumab govitecan in the treatment of metastatic triple negative breast cancer. Onkologie, 17(3), 160-163. https://doi.org/10.36290/xon.2023.032
Palácová, Markéta. “Sacituzumab Govitecan in the Treatment of Metastatic Triple Negative Breast Cancer”. Onkologie 17, no. 3 (2023): 160-63. https://doi.org/10.36290/xon.2023.032.
Palácová M. Sacituzumab govitecan in the treatment of metastatic triple negative breast cancer. Onkologie. 2023;17(3):160-3.